Protein phosphatase 1α activity prevents oncogenic transformation

Molecular Carcinogenesis

Volumn 45, Issue 9, 2006, Pages 648-656

  Liu, Cathy W Y ^a   Wang, Rui Hong ^a,b   Berndt, Norbert ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Apoptosis; Cell cycle; Cyclin D; Protein phosphatase 1; Ras; Retinoblastoma protein

Indexed keywords

AGAR; CASPASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MUTANT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 1ALPHA; RAS PROTEIN; RETINOBLASTOMA PROTEIN; THREONINE; UNCLASSIFIED DRUG; PHOSPHOPROTEIN PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; APOPTOSIS; DRUG ANTAGONISM; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CASPASES; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; HUMANS; MICE; MUTATION; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RAS PROTEINS; RETINOBLASTOMA PROTEIN; THREONINE; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33748801708     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20191     Document Type: Article

References (63)

1. Zetterberg A, Larsson O, Wiman KG. What is the restriction point? Curr Opin Cell Biol 1995;7:835-842.
2. Reed SI. G1/S regulatory mechanisms from yeast to man. In: Meijer L, Guidet S, Vogel L, editors. Progress in cell cycle research, Vol. 2. New York, NY: Plenum Press; 1996. pp 15-27.
3. Planas-Silva MD, Weinberg RA. The restriction point and control of cell proliferation. Curr Opin Cell Biol 1997;9:768-772.
4. Blagosklonny M, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002;1:103-110.
5. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
6. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-112.
7. Massague J. G1 cell-cycle control and cancer. Nature 2004;432:298-306.
8. Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000;14:2393-2409.
9. Chau BN, Wang JYJ. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003;3:130-138.
10. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005;24:2796-2809.
11. Ludlow JW, Glendening CL, Livingston DM, DeCaprio JA. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 1993;13:367-372.
12. Alberts AS, Thorburn AM, Shenolikar S, Mumby MC, Feramisco JR. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. Proc Natl Acad Sci USA 1993;90:388-392.
13. Durfee T, Becherer K, Chen P-L, et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 1993;7:555-569.
14. Berndt N. Phosphorylation of protein phosphatase 1 by cyclin-dependent kinases: A novel mechanism for cell cycle control? Adv Prot Phosphatases 1995;9:63-86.
15. Dohadwala M, Da Cruz e Silva EF, Hall FL, et al. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc Natl Acad Sci USA 1994;91:6408-6412.
16. Liu CWY, Wang R-H, Dohadwala M, Schönthal AH, Villa-Moruzzi E, Berndt N. Inhibitory phosphorylation of PP1α catalytic subunit during the G1/S transition. J Biol Chem 1999;274:29470-29475.
17. Yamano H, Ishii K, Yanagida M. Phosphorylation of dis2 protein phosphatase at the C-terminal cdc2 consensus and its potential role in cell cycle regulation. EMBO J 1994;13:5310-5318.
18. Kwon Y-G, Lee S-Y, Choi Y, Greengard P, Nairn AC. Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase. Proc Natl Acad Sci USA 1997;94:2168-2173.
19. Puntoni F, Villa-Moruzzi E. Protein phosphatase-1α, γ1, and δ: Changes in phosphorylation and activity in mitotic HeLa cells and in cells released from the mitotic block. Arch Biochem Biophys 1997;340:177-184.
20. Berndt N, Dohadwala M, Liu CWY. Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells. Curr Biol 1997;7:375-386.
21. Wang R-H, Liu CWY, Avramis VI, Berndt N. Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 2001;20:6111-6121.
22. Berndt N. Roles and regulation of serine/threonine-specific protein phosphatases in the cell cycle. In: Meijer L, Jézéquel A, Roberge M, editors. Progress in cell cycle research, Vol. 5. Roscoff, France: Editions "Life in Progress"; 2003. pp 497-510.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning - A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
24. Cox AD, Der CJ. Biological assays for cellular transformation. Methods Enzymol 1994;238:277-294.
25. Motulsky H. Intuitive biostatistics. New York, NY: Oxford University Press; 1995.
26. Fiscella M, Zhang HL, Fan SJ, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 1997;94:6048-6053.
27. Guthridge MA, Bellosta P, Tavoloni N, Basilico C. FIN13, a novel growth factor-inducible serine-threonine phosphatase which can inhibit cell cycle progression. Mol Cell Biol 1997;17:5485-5498.
28. Baharians Z, Schönthal AH. Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase 2A. Mol Carcinog 1999;24:246-254.
29. Nakamura K, Koda T, Kakinuma M, et al. Cell cycle dependent gene expressions and activities of protein phosphatases PP1 and PP2A in mouse NIH3T3 fibroblasts. Biochem Biophys Res Commun 1992;187:507-514.
30. Villa-Moruzzi E, Puntoni F. Phosphorylation of phosphatase-1α in cells expressing v-src. Biochem Biophys Res Commun 1996;219:863-867.
31. 1 progression in NIH 3T3 cells. Mol Cell Biol 1995;15:3654-3663.
32. Peeper DS, Upton TM, Ladha MH, et al. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 1997;386:177-180.
33. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994;91:709-713.
34. Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation. Oncogene 1994;9:323-326.
35. Mittnacht S, Paterson H, Olson MF, Marshall CJ. Ras signalling is required for inactivation of the tumor suppressor pRb cell-cycle control protein. Curr Biol 1997;7:219-221.
36. Jänicke RU, Walker PA, Lin XY, Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996;15:6969-6978.
37. Chen W, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 1997;14:1243-1248.
38. Reeder JE, Sowden MP, Messing EM, Klover P, Villa-Moruzzi E, Ludlow JW. Inducible expression of catalytically active type I serine/threonine protein phosphatase in a human carcinoma cell line. Cancer Cell Int 2003;3. http://www. cancerci.com/content/3/1/12
39. Calabro V, Parisi T, Di Cristofano A, La Mantia G. Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties. Oncogene 1999;18:2157-2162.
40. Yamashita A, Hakura A, Inoue H. Suppression of anchorage-independent growth of human cancer cell lines by the drs gene. Oncogene 1999;18:4777-4787.
41. Yang Z-Y, Perkins ND, Ohno T, Nabel EG, Nabel GJ. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1995;1:1052-1056.
42. waf1/cip1 arrests the growth of chicken embryo fibroblasts transformed by individual oncogenes. Oncogene 1995;11:2609-2618.
43. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, Xiong Y. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 1998;95:1392-1397.
44. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 1998;16:1839-1849.
45. Van Rompaey L, Potter M, Adams C, Grosveld G. Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene 2000;19:5244-5250.
46. Zhou P, Jiang W, Zhang Y-J, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 1995;11:571-580.
47. Arber N, Doki Y, Han EKH, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 1997;57:1569-1574.
48. Lee SW, Reimer CL, Fang L, Iruela-Arispe ML, Aaronson SA. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol 2000;20:1723-1732.
49. Inbal B, Cohen O, Polak-Charcon S, et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997;390:180-184.
50. ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 2001;3:1-7.
51. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990;247:712-715.
52. Knudsen KE, Weber E, Arden KC, Cavenee WK, Feramisco JR, Knudsen ES. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death. Oncogene 1999;18:5239-5245.
53. Jiang Z, Zacksenhaus E. Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J Cell Biol 2002;156:185-198.
54. Haas-Kogan DA, Kogan SC, Levi D, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995;14:461-472.
55. Berry DE, Lu Y, Schmidt B, et al. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene 1996;12:1809-1819.
56. Fan G, Ma X, Kren BT, Steer CJ. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996;12:1909-1919.
57. McConkey DJ, Goodrich D, Bucana C, Klostergaard J. The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene 1996;13:1693-1700.
58. Huchon D, Ozon R, Demaille JG. Protein phosphatase-1 is involved in Xenopus oocyte maturation. Nature 1981;294:358-359.
59. Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S. PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J 2003;22:5734-5745.
60. Doonan JH, Morris NR. The bimG gene of Aspergillus nidulans, required for completion of anaphase, encodes a homolog of mammalian phosphoprotein phosphatase 1. Cell 1989;57:987-996.
61. 2+ gene required for chromosome disjoining encodes one of two putative type 1 protein phosphatases. Cell 1989;57:997-1007.
62. 1+ in fission yeast mitotic control. Cell 1989;57:1009-1016.
63. Fernandez A, Brautigan DL, Lamb NJC. Protein phosphatase type 1 in mammalian cell mitosis: Chromosomal localization and involvement in mitotic exit. J Cell Biol 1992;116:1421-1430.